Molecular and socioeconomic characteristics of inflammatory breast cancer in the Carolina Breast Cancer Study.
1/5 보강
[PURPOSE] Inflammatory breast cancer (IBC) has been hypothesized to represent a distinct molecular subtype.
- 표본수 (n) 4,739
- OR 1.53
APA
Wang Q, Van Alsten SC, et al. (2026). Molecular and socioeconomic characteristics of inflammatory breast cancer in the Carolina Breast Cancer Study.. Breast cancer research and treatment, 215(2), 61. https://doi.org/10.1007/s10549-025-07884-3
MLA
Wang Q, et al.. "Molecular and socioeconomic characteristics of inflammatory breast cancer in the Carolina Breast Cancer Study.." Breast cancer research and treatment, vol. 215, no. 2, 2026, pp. 61.
PMID
41569442
Abstract
[PURPOSE] Inflammatory breast cancer (IBC) has been hypothesized to represent a distinct molecular subtype. However, few IBC-specific gene expression patterns have been identified, and previous genomic studies of IBC have been small with limited information on social determinants.
[METHODS] We identified 153 IBC cases in the Carolina Breast Cancer Study (total N = 4,739). RNA expression was measured on the NanoString platform (N = 74 IBC, 2,696 non-IBC) and used to determine molecular subtypes, including PAM50, immune, homologous recombination deficiency (HRD), and P53 status. We estimated odds ratios (ORs) and 95% confidence intervals (CIs) of associations between IBC and patient demographic, molecular, and social characteristics using logistic regression, and compared differences in gene expression using ANOVA.
[RESULTS] Women with IBC were associated with Black and under 50 compared to non-IBC. IBC was associated with rural address (OR = 1.53) and poverty (OR = 1.61). Molecularly, IBC was associated with HER2-enriched (OR = 6.14), Luminal B (OR = 2.90), P53 Mutant-like (OR = 1.79), and high HRD (OR = 1.90). Neither adiposity nor immune subtype was significantly associated with IBC. Only six of 219 genes measured were significantly differentially expressed between IBC and non-IBC, including HER2-related (ERBB2, FGFR4, GRB7) and P53-related genes (BTG2, LOC400043, MAP2K4).
[CONCLUSION] Although not associated with immune subtypes, IBC showed differences in HER2 and P53 pathways. The association of IBC with rurality and poverty underscores the importance of health care access for timely diagnosis and treatment of IBC.
[METHODS] We identified 153 IBC cases in the Carolina Breast Cancer Study (total N = 4,739). RNA expression was measured on the NanoString platform (N = 74 IBC, 2,696 non-IBC) and used to determine molecular subtypes, including PAM50, immune, homologous recombination deficiency (HRD), and P53 status. We estimated odds ratios (ORs) and 95% confidence intervals (CIs) of associations between IBC and patient demographic, molecular, and social characteristics using logistic regression, and compared differences in gene expression using ANOVA.
[RESULTS] Women with IBC were associated with Black and under 50 compared to non-IBC. IBC was associated with rural address (OR = 1.53) and poverty (OR = 1.61). Molecularly, IBC was associated with HER2-enriched (OR = 6.14), Luminal B (OR = 2.90), P53 Mutant-like (OR = 1.79), and high HRD (OR = 1.90). Neither adiposity nor immune subtype was significantly associated with IBC. Only six of 219 genes measured were significantly differentially expressed between IBC and non-IBC, including HER2-related (ERBB2, FGFR4, GRB7) and P53-related genes (BTG2, LOC400043, MAP2K4).
[CONCLUSION] Although not associated with immune subtypes, IBC showed differences in HER2 and P53 pathways. The association of IBC with rurality and poverty underscores the importance of health care access for timely diagnosis and treatment of IBC.
MeSH Terms
Humans; Female; Middle Aged; Inflammatory Breast Neoplasms; North Carolina; Adult; Aged; Socioeconomic Factors; Biomarkers, Tumor
같은 제1저자의 인용 많은 논문 (5)
- Experience of family caregivers of breast cancer-related lymphedema patients participating in lymphedema management: a phenomenological study.
- [cGAS-STING agonist cGAMP enhances natural killer cell-mediated cytotoxicity against gastric cancer cells].
- Editorial for "Intratumoral Spatial Heterogeneity at Dynamic Contrast-Enhanced MRI for Assessing Tertiary Lymphoid Structures in Hepatocellular Carcinoma".
- Analytical and computational chemistry approaches for mechanistic insights into nanoparticles tumor access.
- Role of radiotherapy in the treatment of -mutant non-small-cell lung cancer: a narrative review.